Compare Mongodb Inc (MDB) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mongodb Inc vs Novavax Inc — how do they compare? Mongodb Inc trades at $323.5 (market cap $26.01B), while Novavax Inc trades at $7.9 (market cap $1.30B). The key difference: Mongodb Inc is far larger — about 20× Novavax Inc's market cap, and Mongodb Inc is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| MDB | NVAX | |
|---|---|---|
Market Cap | $26.01B | $1.30B |
Sector | Technology | Health |
52-Week High | $440.25 | $11.19 |
52-Week Low | $201.08 | $6.22 |
Enterprise Value | $23.61B | $800.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
